AliveCor
PrivateLast Round
Series F
Aug 16, 2022
Est. Valuation
$88.15M
Total Funding Raised
$159.38M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AliveCor is a healthcare technology company that develops FDA-cleared personal electrocardiogram (ECG) devices and AI-powered software for remote cardiac monitoring.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Health IoT, Consumer Electronics, Telemedicine
Business Model
B2C
Customer Profile
Hardware + Subscription, Hardware Sales, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AliveCor Comparables
Compare AliveCor with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Coala-Life Group AB | 81% | |
| CardiacSense | 81% | |
| CardioComm Solutions, Inc. | 78% |
AliveCor Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series F | Aug 16, 2022 | ||||
| Series E | Nov 16, 2020 | ||||
| VC Round | Oct 21, 2019 | ||||
| Debt | Jan 28, 2019 | ||||
| Series D | Mar 16, 2017 | ||||
Series C | Mar 31, 2016 |
Key People
Founding team and executive leadership
AliveCor Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| WP Global Partners | Series F, Series C, Series E |
| Oklahoma Life Science Fund | Series A, Series B |
| Khosla Ventures | Series F, Series D, Series B, Series E |
| Qualcomm Ventures | Series F, Series B, Series D, Series A, Series E |
| Burrill and Company | Series A, Series B |
| NGK Spark Plug | Series F |
| BOLD Capital Partners | Series D, Series F, Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 26, 2026
Added Vhss1, a startup in Government Contracting / Healthcare Services.
- Apr 7, 2026
Expanding AI cardiac diagnostics services and opening offices in Vietnam.
Recent news
Latest coverage and updates
- launchesSep 15, 2026
AliveCor, Inc. launched KardiaACCESS on Sep 15th '26.
- has_issues_withAug 10, 2026
AliveCor, Inc. had issues with ransomware attack on Aug 10th '26.
- identified_as_competitor_ofJul 29, 2026
AliveCor, Inc. identified as competitor of Eko Health, Inc..
AliveCor Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AliveCor's valuation, stock price, and market status.
Is AliveCor a public or private company?
AliveCor is a private company.
What is the current stock price of AliveCor?
AliveCor is a private company with no public stock price. No recent secondary market data is available.
How much is AliveCor worth (valuation)?
Valuation information for AliveCor is not publicly available.
Can I buy AliveCor stock?
AliveCor shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AliveCor's last funding round?
AliveCor's most recent funding round was Series F on August 16, 2022.
Who are the main investors in AliveCor?
Key investors in AliveCor include WP Global Partners, Khosla Ventures, Qualcomm Ventures, BOLD Capital Partners, Oxford Finance.
Will AliveCor IPO soon?
No public IPO plans have been announced for AliveCor.
How can I track AliveCor secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AliveCor's secondary market activity and sign up for updates.